ERBB2 and gastric cancer: Although gastric cancer develops through the accumulation of genetic alterations, such as oncogene (e.g. HER2, c-Met) activation and tumor suppressor gene (e.g. PTEN, p53) loss [3–6], the underlying molecular mechanisms of gastric carcinogenesis are largely unknown.